藍莓聯(lián)合益生菌對非酒精性脂肪性肝病模型大鼠PNPLA3和SREBP-1c表達的影響
發(fā)布時間:2018-05-11 02:01
本文選題:脂肪肝 + 含patatin樣磷脂酶域。 參考:《臨床肝膽病雜志》2016年09期
【摘要】:目的觀察含patatin樣磷脂酶域3(PNPLA3)和膽固醇調(diào)節(jié)元件結(jié)合蛋白(SREBP)1c在藍莓聯(lián)合益生菌對非酒精性脂肪性肝病(NAFLD)模型大鼠干預實驗中的表達,并探討其在NAFLD中的作用機制。方法清潔級SD大鼠36只分為正常組(NG)、模型組(MG)、自然恢復組(SRG)、藍莓組(BG)、益生菌組(PG)和藍莓聯(lián)合益生菌組(BPG)。實驗結(jié)束后,制作組織切片,觀察血清學、組織學形態(tài)變化,檢測PNPLA3和SREBP-1c基因及蛋白表達情況。多組間比較用單因素方差分析,方差齊時用SNK-q檢驗,方差不齊時用Tamhane's-T2檢驗。結(jié)果 6組間在肝臟指數(shù)、ALT、TC、TG、LDL和HDL上差異均有統(tǒng)計學意義(F值分別為384.908、188.554、75.523、94.667、95.235、132.586,P值均0.01)。6組間NAFLD活動度積分差異有統(tǒng)計學意義(F=71.896,P0.01),其中BPG組較MG、SRG、BG、PG組下降最為顯著(P值均0.01)。6組肝組織表達PNPLA3和SREBP-1c陽性率差異均有統(tǒng)計學意義(F值分別為175.527、110.504,P值均0.01),其中BPG組較MG、SRG、BG、PG組下降最為顯著(P值均0.01)。PNPLA3和SREBP-1c的mRNA和蛋白表達各組間差異有統(tǒng)計學意義(F值分別為375.822、410.379、288.940、116.054,P值均0.01)。其中BPG組的PNPLA3和SREBP-1C的mRNA和蛋白表達較MG、SRG、BG、PG組明顯下降(P值均0.01)。結(jié)論藍莓聯(lián)合益生菌能有效改善NAFLD的病理組織結(jié)構(gòu),減輕肝細胞脂肪變性,其機制可能是藍莓與益生菌聯(lián)合可減輕炎癥因子誘發(fā)的炎癥效應,下調(diào)SREBP-1c的表達,從而減弱PNPLA3基因轉(zhuǎn)錄,增強膽固醇代謝,減少脂質(zhì)沉積,是NAFLD的一個輔助治療方案。
[Abstract]:Objective to observe the expression of patatin-like phospholipase domain 3 (PNPLA3) and cholesterol regulatory element binding protein (SREBP1c) in the intervention experiment of blueberry combined with probiotics in rats with nonalcoholic fatty liver disease (NAF LDD) and to explore the mechanism of its role in NAFLD. Methods Thirty-six SD rats of clean grade were divided into normal group, model group, natural recovery group, blueberry group, probiotics group (PGN) and blueberry combined probiotics group. At the end of the experiment, tissue sections were made, serological and histological changes were observed, and the expression of PNPLA3 and SREBP-1c genes and proteins were detected. Single factor analysis of variance (ANOVA) was used in multigroup comparison, SNK-q test was used when variance was homogeneous, and Tamhane's-T2 test was used when variance was uneven. Results there were significant differences in NAFLD activity scores between the six groups on the liver index (alt) and HDL (P = 384.908188.554, P = 75.5239.667.65.235132.586p, respectively). There was a significant difference in NAFLD activity between the six groups (F71.896a, P0.01P). The BPG group had the most significant decrease compared with the MGG group (P < 0.01). The difference of PNPLA3 and SREBP-1c positive rate was statistically significant (F = 175.527110.504 P = 0.01), in which the mRNA and protein expression of 0.01).PNPLA3 and SREBP-1c in BPG group were significantly lower than those in MGG BPG group (P = 375.822410.379, 288.940116.054, P < 0.01). The expression of mRNA and protein in PNPLA3 and SREBP-1C in BPG group was significantly lower than that in MGG group. Conclusion the combination of blueberry and probiotics can effectively improve the pathological structure of NAFLD and reduce the steatosis of hepatocytes. The mechanism may be that the combination of blueberry and probiotics can reduce the inflammatory effect induced by inflammatory factors and down-regulate the expression of SREBP-1c. It is an adjuvant therapy for NAFLD to reduce the transcription of PNPLA3 gene, enhance cholesterol metabolism and reduce lipid deposition.
【作者單位】: 貴州醫(yī)科大學附屬醫(yī)院感染科;
【基金】:貴州省科技廳社會攻關(guān)資助項目(黔科合SY[2010]3017號) 黔東南苗族侗族自治州林業(yè)局科研基金資助項目(ZLYJZFCG-2012-7)
【分類號】:R575.5;R-332
【相似文獻】
相關(guān)期刊論文 前2條
1 ;你怎樣才能更聰明[J];IT時代周刊;2011年Z1期
2 ;[J];;年期
,本文編號:1871902
本文鏈接:http://sikaile.net/xiyixuelunwen/1871902.html
最近更新
教材專著